• Groundbreaking myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities

    Dec 4, 2025, 08:38 by
    PrecisionLife has announced new findings from the most detailed genetic analysis of myalgic encephalomyelitis ever conducted offering potential for faster and lower-risk routes to developing targeted treatments.
    Full story
  • Next-Generation Immunotherapy Nears the Clinic with Dual Cancer Trials

    Dec 3, 2025, 01:01 by User Not Found
    Clinical Research News | Glycans are the complex sugar chains found at abnormally high levels on the surface of cancer cells—and one of the toughest challenges in cancer treatment. A research team from the UC Irvine School of Medicine developed glycan-dependent T cell recruiters (GlyTRs), which represent a first-of-its-kind approach that bypasses traditional antibody mechanisms to attack cancer’s sugar-coated armor.
    Full story
  • Space Health Research Could Rack Up Many Earthly Dividends

    Dec 2, 2025, 01:01 by User Not Found
    Clinical Research News | When the first all-civilian spaceflight, Inspiration4, was launched by SpaceX in 2021, it set into orbit the idea of future space habitation. It also marked the start of a long-term mission to understand the impact of the journey on everyday people without extensive astronaut training.
    Full story
  • Bioscript Group launches new AI-augmented platform helping medical affairs teams transform data into action

    Dec 1, 2025, 08:57 by
    Full story
  • Symbiosis Formally Presented with Prestigious King’s Award by Lord Lieutenant of Stirling and Falkirk

    Nov 26, 2025, 08:07 by
    Full story
  • Follow the Money: Hypertrophic Cardiomyopathy Therapeutic Candidate, Underserved Bleeding Disorders, Rare Disease Trials

    Nov 25, 2025, 01:16 by User Not Found
    Clinical Research News | Braveheart will advance their small molecule therapeutic candidate, BHB-1893, for hypertrophic cardiomyopathy; Hemab Therapeutics will keep developing sutacimig as the first-ever prophylactic treatment for Glanzmann thrombasthenia (GT); AAVantgarde will continue to work on their trials for treatments for Stargardt disease and Usher 1B; and more.
    Full story
  • Biopharma PEG Offers In-Stock Monodispersed PEGs at Competitive Prices

    Nov 24, 2025, 07:59 by
    Full story
  • Celerion Welcomes Dr. Steven Evans as Senior Cardiologist to Enhance Cardiovascular Safety in Clinical Trials

    Nov 24, 2025, 07:59 by
    Celerion announced the appointment of Dr. Steven Evans as Senior Cardiologist.
    Full story
  • Walgreens Launches New Patient Advisory Board, Advocate Health National Center for Clinical Trials Announced, P95, Julius Clinical Merge

    Nov 24, 2025, 01:01 by User Not Found
    Clinical Research News | Walgreens launches the Walgreens Pharmacy Patient Advisory Board; Advocate Health announces Advocate Health National Center for Clinical Trials, the U.S.’s first, largest, and most inclusive clinical trial network; P95 and Julius Clinical have merged to form a global, full-service clinical research organization; and more.
    Full story
  • WCG Introduces Breakthrough Analytics to Optimize and Accelerate Clinical Trial Outcomes

    Nov 21, 2025, 08:03 by
    WCG has launched its next-generation Data & Insights Solutions, redefining the clinical trial landscape by equipping sponsors and clinical research organizations (CROs) with the trial intelligence, clarity, and objectivity necessary to anticipate challenges, optimize outcomes, and accelerate breakthroughs for patients.
    Full story
  • WCG Unveils 2025 Site Challenges Report to Fuel Clinical Research Transformation

    Nov 21, 2025, 08:03 by
    WCG announced the release of the 2025 Site Challenges Report, offering exclusive insights into the evolving landscape of clinical trial sites worldwide.
    Full story
  • Checking the Boxes for Expanding Trial Start-ups to New Countries

    Nov 21, 2025, 01:01 by User Not Found
    Clinical Research News | The patient-centered approach that has come into favor for planning and conducting clinical trials is, without question, improving care for trial participants. However, combined with other industry trends, including the proliferation of rare disease studies with much smaller patient pools, it is causing trial protocols to become more complex and is creating challenges in patient recruitment, which can lead to costly delays in a competitive and challenging macroeconomic environment.
    Full story
  • Primerdesign Launches exsig Mag RapidBead Pro Extraction Kit for DNA and RNA

    Nov 20, 2025, 08:22 by
    Next-generation magnetic bead-based kit designed for fast and efficient nucleic acid purification from diverse sample types
    Full story
  • Symbiosis Builds Global Business Development Strength with Two North American Appointments

    Nov 20, 2025, 08:22 by
    Full story
  • Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical Drugs Using Quantitative Gene Expression

    Nov 20, 2025, 08:22 by
    Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in early-phase clinical research.
    Full story
  • Early Rheumatoid Arthritis Studies Redefine Prevention and Clinical Research

    Nov 19, 2025, 01:00 by User Not Found
    Clinical Research News | Rheumatoid arthritis has a reputation as a lifelong condition with no real cure and can only be managed after symptoms appear. However, researchers from the Allen Institute for Immunology, University of California, San Diego, and the University of Colorado Anschutz, have mapped out a way to detect dramatic immune system changes before the joints start swelling.
    Full story
  • Pioneering Platform for Collecting ‘Home-Reported Outcomes’

    Nov 18, 2025, 01:01 by User Not Found
    Clinical Research News | As anyone contending with a complex chronic disease can likely attest, a lot has been “left on the table” when it comes to opportunities to achieve better health outcomes, lower costs, and greater personal satisfaction with their medical care. Tens of thousands of patients have voted for change by registering for the Folia Health app, which allows them to track their symptoms and share data about their own healthcare experiences with their care team or research studies.
    Full story
  • Advarra and IgniteData announce partnership to simplify clinical trial data transfer for research sites

    Nov 13, 2025, 08:14 by
    IgniteData’s Archer platform will connect the site’s EHR system, Advarra’s eSource and EDC systems, and the sponsor’s EDC system of choice, ensuring compatibility between solutions from different vendors.
    Full story
  • CluePoints Data and Knowledge Manager Appointed to ACT Editorial Advisory Board

    Nov 12, 2025, 07:45 by
    CluePoints, provider of leading statistical and AI-driven software solutions, has announced Sylviane de Viron, its Data and Knowledge Manager, has been appointed to the Applied Clinical Trials (ACT) editorial advisory board.
    Full story
  • Making Sense of Sex in Clinical Trials

    Nov 12, 2025, 01:01 by User Not Found
    Clinical Research News | Roughly two-thirds of pivotal clinical trials leading to a drug approval by the U.S. Food and Drug Administration (FDA) now include women at rates either at or above the disease burden on the female population. Yet progress on their inclusion has “plateaued” since the FDA began releasing its Drug Trials Snapshots in 2015 because of “fundamental issues in not considering female biology."
    Full story
  • «
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19 (current)
  • 20
  • »